EGFR and glioblastoma: Accordingly to the literature, fifty percent of GBM CSC examined in the current study had shown overexpression of EGFR, which resulted independently from Notch1 activation, despite other laboratories’ reports that Notch and EGFR signaling pathways converge to regulate the same gene targets.